ALFONSO VALENCIA Spanish National Cancer Research Centre

Total Page：16

File Type：pdf, Size：1020Kb

ALFONSO VALENCIA Spanish National Cancer Research Centre

Simposio Internacional: : La biología de las redes proteicas: el interactoma y sus implicaciones patológicas International Symposium: Biology of protein networks: Implications for human disease Barcelona, 6 y 7 de octubre de 2015 Barcelona, October 6-7, 2015 ALFONSO VALENCIA Spanish National Cancer Research Centre, CNIO Alfonso Valencia is a biologist with formal training in population genetics and biophysics which he received from the Universidad Complutense de Madrid. He was awarded his PhD in 1988 at the Universidad Autónoma de Madrid. He was a Visiting Scientist at the American Red Cross Laboratory in 1987 and from 1989-1994 was a Postdoctoral Fellow at the laboratory of C. Sander at the European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. In 1994 Alfonso Valencia set up the Protein Design Group at the Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC) in Madrid where he was appointed as Research Professor in 2005. He is a Member of the European Molecular Biology Organisation (EMBO), Founder and former Vice President of the International Society for Computational Biology where he has been Chair of the Systems Biology and/or Text Mining Tracks of the main Computational Biology Annual Conference (ISMB) since 2003. He was honoured as ISCB-Fellow in 2010. Alfonso Valencia serves on the Scientific Advisory Board of the European Molecular Biology Laboratory; the Swiss Institute for Bioinformatics, Biozentrum, Basel; the INTERPRO database; the Spanish Grant Evaluation Agency (ANEP); as well as the Steering Committee of the European Science Foundation Programme on Functional Genomics (2006-2011). Alfonso Valencia is Co-Executive Editor of Bionformatics, serves on the Editorial Board of EMBO Journal and EMBO Reports, among others. He is the Director of the Spanish National Bioinformatics Institute (INB). .

Copy Link

Recommended publications

Semantic Web
SEMANTIC WEB: REVOLUTIONIZING KNOWLEDGE DISCOVERY IN THE LIFE SCIENCES SEMANTIC WEB: REVOLUTIONIZING KNOWLEDGE DISCOVERY IN THE LIFE SCIENCES Edited by Christopher J. O. Baker1 and Kei-Hoi Cheung2 1Knowledge Discovery Department, Institute for Infocomm Research, Singapore, Singapore; 2Center for Medical Informatics, Yale University School of Medicine, New Haven, CT, USA Kluwer Academic Publishers Boston/Dordrecht/London Contents PART I: Database and Literature Integration Semantic web approach to database integration in the life sciences KEI-HOI CHEUNG, ANDREW K. SMITH, KEVIN Y. L. YIP, CHRISTOPHER J. O. BAKER AND MARK B. GERSTEIN Querying Semantic Web Contents: A case study LOIC ROYER, BENEDIKT LINSE, THOMAS WÄCHTER, TIM FURCH, FRANCOIS BRY, AND MICHAEL SCHROEDER Knowledge Acquisition from the Biomedical Literature LYNETTE HIRSCHMAN, WILLIAM HAYES AND ALFONSO VALENCIA PART II: Ontologies in the Life Sciences Biological Ontologies PATRICK LAMBRIX, HE TAN, VAIDA JAKONIENE, AND LENA STRÖMBÄCK Clinical Ontologies YVES LUSSIER AND OLIVIER BODENREIDER Ontology Engineering For Biological Applications vi Revolutionizing knowledge discovery in the life sciences LARISA N. SOLDATOVA AND ROSS D. KING The Evaluation of Ontologies: Toward Improved Semantic Interoperability LEO OBRST, WERNER CEUSTERS, INDERJEET MANI, STEVE RAY AND BARRY SMITH OWL for the Novice JEFF PAN PART III: Ontology Visualization Techniques for Ontology Visualization XIAOSHU WANG AND JONAS ALMEIDA On Vizualization of OWL Ontologies SERGUEI KRIVOV, FERDINANDO VILLA, RICHARD WILLIAMS, AND XINDONG WU PART IV: Ontologies in Action Applying OWL Reasoning to Genomics: A Case Study KATY WOLSTENCROFT, ROBERT STEVENS AND VOLKER HAARSLEV Can Semantic Web Technologies enable Translational Medicine? VIPUL KASHYAP, TONYA HONGSERMEIER AND SAMUEL J. ARONSON Ontology Design for Biomedical Text Mining RENÉ WITTE, THOMAS KAPPLER, AND CHRISTOPHER J.
[Show full text]
Aggregation and Correlation Toolbox for Analyses of Genome Tracks Justin Jee Yale University
University of Massachusetts eM dical School eScholarship@UMMS Program in Bioinformatics and Integrative Biology Program in Bioinformatics and Integrative Biology Publications and Presentations 4-15-2011 ACT: aggregation and correlation toolbox for analyses of genome tracks Justin Jee Yale University Joel Rozowsky Yale University Kevin Y. Yip Yale University See next page for additional authors Follow this and additional works at: http://escholarship.umassmed.edu/bioinformatics_pubs Part of the Bioinformatics Commons, Computational Biology Commons, and the Systems Biology Commons Repository Citation Jee, Justin; Rozowsky, Joel; Yip, Kevin Y.; Lochovsky, Lucas; Bjornson, Robert; Zhong, Guoneng; Zhang, Zhengdong; Fu, Yutao; Wang, Jie; Weng, Zhiping; and Gerstein, Mark B., "ACT: aggregation and correlation toolbox for analyses of genome tracks" (2011). Program in Bioinformatics and Integrative Biology Publications and Presentations. Paper 26. http://escholarship.umassmed.edu/bioinformatics_pubs/26 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in Bioinformatics and Integrative Biology Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. ACT: aggregation and correlation toolbox for analyses of genome tracks Authors Justin Jee, Joel Rozowsky, Kevin Y. Yip, Lucas Lochovsky, Robert Bjornson, Guoneng Zhong, Zhengdong Zhang, Yutao Fu, Jie Wang, Zhiping Weng, and Mark B. Gerstein Comments © The Author(s) 2011. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
[Show full text]
Biocreative II.5 Workshop 2009 Special Session on Digital Annotations
BioCreative II.5 Workshop 2009 Special Session on Digital Annotations The puriﬁed IRF-4 was also The main role of BRCA2 shown to be capable of binding appears to involve regulating the DNA in a PU.1-dependent manner function of RAD51 in the repair by by electrophoretic mobility shift homologous recombination . analysis. brca2 irf4 We found that cells ex- Moreover, expression of pressing Olig2, Nkx2.2, and NG2 Carma1 induces phosphorylation were enriched among virus- of Bcl10 and activation of the infected, GFP-positive (GFP+) transcription factor NF-kappaB. cells. carma1 BB I O olig2 The region of VHL medi- The Rab5 effector ating interaction with HIF-1 alpha Rabaptin-5 and its isoform C R E A T I V E overlapped with a putative Rabaptin-5delta differ in their macromolecular binding site within ability to interact with the rsmallab5 the crystal structure. GTPase Rab4. vhl Translocation RCC, bearing We show that ERBB2-dependenterbb2 atf1 TFE3 or TFEB gene fusions, are Both ATF-1 homodimers and tfe3 medulloblastoma cell invasion and ATF-1/CREB heterodimers bind to recently recognized entities for prometastatic gene expression can the CRE but not to the related which risk factors have not been be blocked using the ERBB tyrosine phorbol ester response element. identiﬁed. kinase inhibitor OSI-774. C r i t i c a l A s s e s s m e n t o f I n f o r m a t i o n E x t r a c t i o n i n B i o l o g y October 7th - 9th, 2009 www.BioCreative.org BioCreative II.5 Workshop 2009 special session | Digital Annotations Auditorium of the Spanish National
[Show full text]
Tporthmm : Predicting the Substrate Class Of
TPORTHMM : PREDICTING THE SUBSTRATE CLASS OF TRANSMEMBRANE TRANSPORT PROTEINS USING PROFILE HIDDEN MARKOV MODELS Shiva Shamloo A thesis in The Department of Computer Science Presented in Partial Fulfillment of the Requirements For the Degree of Master of Computer Science Concordia University Montréal, Québec, Canada December 2020 © Shiva Shamloo, 2020 Concordia University School of Graduate Studies This is to certify that the thesis prepared By: Shiva Shamloo Entitled: TportHMM : Predicting the substrate class of transmembrane transport proteins using profile Hidden Markov Models and submitted in partial fulfillment of the requirements for the degree of Master of Computer Science complies with the regulations of this University and meets the accepted standards with respect to originality and quality. Signed by the final examining commitee: Examiner Dr. Sabine Bergler Examiner Dr. Andrew Delong Supervisor Dr. Gregory Butler Approved Dr. Lata Narayanan, Chair Department of Computer Science and Software Engineering 20 Dean Dr. Mourad Debbabi Faculty of Engineering and Computer Science Abstract TportHMM : Predicting the substrate class of transmembrane transport proteins using profile Hidden Markov Models Shiva Shamloo Transporters make up a large proportion of proteins in a cell, and play important roles in metabolism, regulation, and signal transduction by mediating movement of compounds across membranes but they are among the least characterized proteins due to their hydropho- bic surfaces and lack of conformational stability. There is a need for tools that predict the substrates which are transported at the level of substrate class and the level of specific substrate. This work develops a predictor, TportHMM, using profile Hidden Markov Model (HMM) and Multiple Sequence Alignment (MSA).
[Show full text]
MPGM: Scalable and Accurate Multiple Network Alignment
MPGM: Scalable and Accurate Multiple Network Alignment Ehsan Kazemi1 and Matthias Grossglauser2 1Yale Institute for Network Science, Yale University 2School of Computer and Communication Sciences, EPFL Abstract Protein-protein interaction (PPI) network alignment is a canonical operation to transfer biological knowledge among species. The alignment of PPI-networks has many applica- tions, such as the prediction of protein function, detection of conserved network motifs, and the reconstruction of species’ phylogenetic relationships. A good multiple-network align- ment (MNA), by considering the data related to several species, provides a deep understand- ing of biological networks and system-level cellular processes. With the massive amounts of available PPI data and the increasing number of known PPI networks, the problem of MNA is gaining more attention in the systems-biology studies. In this paper, we introduce a new scalable and accurate algorithm, called MPGM, for aligning multiple networks. The MPGM algorithm has two main steps: (i) SEEDGENERA- TION and (ii) MULTIPLEPERCOLATION. In the first step, to generate an initial set of seed tuples, the SEEDGENERATION algorithm uses only protein sequence similarities. In the second step, to align remaining unmatched nodes, the MULTIPLEPERCOLATION algorithm uses network structures and the seed tuples generated from the first step. We show that, with respect to different evaluation criteria, MPGM outperforms the other state-of-the-art algo- rithms. In addition, we guarantee the performance of MPGM under certain classes of net- work models. We introduce a sampling-based stochastic model for generating k correlated networks. We prove that for this model if a sufficient number of seed tuples are available, the MULTIPLEPERCOLATION algorithm correctly aligns almost all the nodes.
[Show full text]
You Are Cordially Invited to a Talk in the Edmond J. Safra Center for Bioinformatics Distinguished Speaker Series
You are cordially invited to a talk in the Edmond J. Safra Center for Bioinformatics Distinguished Speaker Series. The speaker is Prof. Alfonso Valencia, Spanish National Cancer Research Centre, CNIO. Title: "A mESC epigenetics network that combines chromatin localization data and evolutionary information" Time: Wednesday, November 11 2015, at 11:00 (refreshments from 10:50) Place: Green building seminar room, ground floor, Biotechnology Department. Host: Prof. Ron Shamir, [email protected], School of Computer Science Abstract: The description of biological systems in terms of networks is by now a well- accepted paradigm. Networks offer the possibility of combining complex information and the system to analyse the properties of individual components in relation to the ones of their interaction partners. In this context, we have analysed the relations between the known components of mouse Embryonic Stem Cells (mESC) epigenome at two orthogonal levels of information, i.e., co-localization in the genome and concerted evolution (co-evolution). Public repositories contain results of ChIP-Seq experiments for more than 60 Chromatin Related Proteins (CRPs), 14 for Histone modifications, and three different types of DNA methylation, including 5-Hydroxymethylcytosine (5hmc). All this information can be summarized in a network in which the nodes are the CRPs, histone marks and DNA modifications and the arcs connect components that significantly co-localize in the genome. In this network co-localization preferences are specific of chromatin states, such as promoters and enhancers. A second network was build by connecting proteins that are part of the mESC epigenetic regulatory system and show signals of co-evolution (concerted evolution of the CRPs protein families).
[Show full text]
ISCB's Initial Reaction to the New England Journal of Medicine
MESSAGE FROM ISCB ISCB’s Initial Reaction to The New England Journal of Medicine Editorial on Data Sharing Bonnie Berger, Terry Gaasterland, Thomas Lengauer, Christine Orengo, Bruno Gaeta, Scott Markel, Alfonso Valencia* International Society for Computational Biology, Inc. (ISCB) * [email protected] The recent editorial by Drs. Longo and Drazen in The New England Journal of Medicine (NEJM) [1] has stirred up quite a bit of controversy. As Executive Officers of the International Society of Computational Biology, Inc. (ISCB), we express our deep concern about the restric- tive and potentially damaging opinions voiced in this editorial, and while ISCB works to write a detailed response, we felt it necessary to promptly address the editorial with this reaction. While some of the concerns voiced by the authors of the editorial are worth considering, large parts of the statement purport an obsolete view of hegemony over data that is neither in line with today’s spirit of open access nor furthering an atmosphere in which the potential of data can be fully realized. ISCB acknowledges that the additional comment on the editorial [2] eases some of the polemics, but unfortunately it does so without addressing some of the core issues. We still feel, however, that we need to contrast the opinion voiced in the editorial with what we consider the axioms of our scientific society, statements that lead into a fruitful future of data-driven science: • Data produced with public money should be public in benefit of the science and society • Restrictions to the use of public data hamper science and slow progress OPEN ACCESS • Open data is the best way to combat fraud and misinterpretations Citation: Berger B, Gaasterland T, Lengauer T, Orengo C, Gaeta B, Markel S, et al.
[Show full text]
Bioinformatics: a Practical Guide to the Analysis of Genes and Proteins, Second Edition Andreas D
BIOINFORMATICS A Practical Guide to the Analysis of Genes and Proteins SECOND EDITION Andreas D. Baxevanis Genome Technology Branch National Human Genome Research Institute National Institutes of Health Bethesda, Maryland USA B. F. Francis Ouellette Centre for Molecular Medicine and Therapeutics Children’s and Women’s Health Centre of British Columbia University of British Columbia Vancouver, British Columbia Canada A JOHN WILEY & SONS, INC., PUBLICATION New York • Chichester • Weinheim • Brisbane • Singapore • Toronto BIOINFORMATICS SECOND EDITION METHODS OF BIOCHEMICAL ANALYSIS Volume 43 BIOINFORMATICS A Practical Guide to the Analysis of Genes and Proteins SECOND EDITION Andreas D. Baxevanis Genome Technology Branch National Human Genome Research Institute National Institutes of Health Bethesda, Maryland USA B. F. Francis Ouellette Centre for Molecular Medicine and Therapeutics Children’s and Women’s Health Centre of British Columbia University of British Columbia Vancouver, British Columbia Canada A JOHN WILEY & SONS, INC., PUBLICATION New York • Chichester • Weinheim • Brisbane • Singapore • Toronto Designations used by companies to distinguish their products are often claimed as trademarks. In all instances where John Wiley & Sons, Inc., is aware of a claim, the product names appear in initial capital or ALL CAPITAL LETTERS. Readers, however, should contact the appropriate companies for more complete information regarding trademarks and registration. Copyright ᭧ 2001 by John Wiley & Sons, Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic or mechanical, including uploading, downloading, printing, decompiling, recording or otherwise, except as permitted under Sections 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the Publisher.
[Show full text]
Keynote Speaker
4th BSC Severo Ochoa Doctoral Symposium KEYNOTE SPEAKER Alfonso Valencia Head of Life Sciences Department, BSC Personalised Medicine as a Computational Challenge Personalized Medicine represents the adoption of Genomics and other –omics technologies to the diagnosis and treatment of diseases. PerMed is one of the more interesting and promising developments resulting from the genomic revolution. The treatment and analysis of genomic information is tremendously challenging for a number of reasons that include the diversity and heterogeneity of the data, strong dependence of the associated metadata (i.e, experimental details), very fast evolution of the methods, and the size and confidentiality of the data sets. Furthermore, the lack of a sufficiently developed conceptual framework in Molecular Biology makes the interpretation of the data extremely difficult. In parallel, the work in human diseases will require the combination of the –omics information with the description of diseases, symptoms, drugs and treatments: The use of this information, recorded in Electronic Medical Records and other associated documents, requires the development and application of Text Mining and Natural Language processing technologies. These problems have to be seen as opportunities, particularly for students and Post Docs in Bioinformatics, Engineering and Computer Sciences. During this talk, I will introduce some of the areas in which the Life Sciences Department works, from Simulation to Genome Analysis, including text mining, pointing to what I see as the most promising future areas of development. Alfonso Valencia is the founder and President of the International Society for Computational Biology and Co-Executive Director of the main journal in the field (Bioinformatics of Oxford University Press).
[Show full text]
Obstacles to Studying Alternative Splicing Using Scrna-Seq
bioRxiv preprint doi: https://doi.org/10.1101/797951; this version posted October 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Obstacles to Studying Alternative Splicing Using scRNA-seq Jennifer Westoby∗1, Pavel Artemovy2, Martin Hembergz3, and Anne Ferguson-Smithx4 1Department of Genetics, University of Cambridge , Downing Street, CB2 3EH 2Department of Genetics, University of Cambridge , Downing Street, CB2 3EH 3Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA 4Department of Genetics, University of Cambridge, Downing Street, CB2 3EH October 8, 2019 ∗Electronic address: [email protected]; Corresponding author yElectronic address: [email protected]; zElectronic address: [email protected]; xElectronic address: [email protected]; 1 bioRxiv preprint doi: https://doi.org/10.1101/797951; this version posted October 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Abstract Background Early single-cell RNA-seq (scRNA-seq) studies suggested that it was unusual to see more than one isoform being produced from a gene in a single cell, even when multiple isoforms were detected in matched bulk RNA-seq samples. How- ever, these studies generally did not consider the impact of dropouts or isoform quantiﬁcation errors, potentially confounding the results of these analyses.
[Show full text]
I S C B N E W S L E T T
ISCB NEWSLETTER FOCUS ISSUE {contents} President’s Letter 2 Member Involvement Encouraged Register for ISMB 2002 3 Registration and Tutorial Update Host ISMB 2004 or 2005 3 David Baker 4 2002 Overton Prize Recipient Overton Endowment 4 ISMB 2002 Committees 4 ISMB 2002 Opportunities 5 Sponsor and Exhibitor Benefits Best Paper Award by SGI 5 ISMB 2002 SIGs 6 New Program for 2002 ISMB Goes Down Under 7 Planning Underway for 2003 Hot Jobs! Top Companies! 8 ISMB 2002 Job Fair ISCB Board Nominations 8 Bioinformatics Pioneers 9 ISMB 2002 Keynote Speakers Invited Editorial 10 Anna Tramontano: Bioinformatics in Europe Software Recommendations11 ISCB Software Statement volume 5. issue 2. summer 2002 Community Development 12 ISCB’s Regional Affiliates Program ISCB Staff Introduction 12 Fellowship Recipients 13 Awardees at RECOMB 2002 Events and Opportunities 14 Bioinformatics events world wide INTERNATIONAL SOCIETY FOR COMPUTATIONAL BIOLOGY A NOTE FROM ISCB PRESIDENT This newsletter is packed with information on development and dissemination of bioinfor- the ISMB2002 conference. With over 200 matics. Issues arise from recommendations paper submissions and over 500 poster submis- made by the Society’s committees, Board of sions, the conference promises to be a scientific Directors, and membership at large. Important feast. On behalf of the ISCB’s Directors, staff, issues are defined as motions and are discussed EXECUTIVE COMMITTEE and membership, I would like to thank the by the Board of Directors on a bi-monthly Philip E. Bourne, Ph.D., President organizing committee, local organizing com- teleconference. Motions that pass are enacted Michael Gribskov, Ph.D., mittee, and program committee for their hard by the Executive Committee which also serves Vice President work preparing for the conference.
[Show full text]
PLOS Computational Biology Associate Editor Handbook Second Edition Version 2.6
PLOS Computational Biology Associate Editor Handbook Second Edition Version 2.6 Welcome and thank you for your support of PLOS Computational Biology and the Open Access movement. PLOS Computational Biology is one of the four community run, Open Access journals published by the Public Library of Science. The journal features works of exceptional significance that further our understanding of living systems at all scales—from molecules and cells, to patient populations and ecosystems—through the application of computational methods. Readers include life and computational scientists, who can take the important findings presented here to the next level of discovery. Since its launch in 2005, PLOS Computational Biology has grown not only in the number of papers published, but also in recognition as a quality publication and community resource. We have every reason to expect that this trend will continue and our team of Associate Editors play an invaluable role in this process. Associate Editors oversee the peer review process for the journal, including evaluating submissions, selecting reviewers, assessing reviewer comments, and making editorial decisions. Together with fellow Editorial Board members and the PLOS CB Team, Associate Editors uphold journal policies and ethical standards and work to promote the PLOS mission to provide free public access to scientific research. PLOS Computational Biology is one of a suite of influential journals published by PLOS. Information about the other journals, the PLOS business model, PLOS innovations in scientific publishing, and Open Access copyright and licensure can be found in Appendix IX. Table of Contents PLOS Computational Biology Editorial Board Membership ................................................................................... 2 Manuscript Evaluation .....................................................................................................................................
[Show full text]